Close Menu

NEW YORK (360Dx) – Accelerate Diagnostics reported after the market closed on Wednesday that its first quarter revenues rose 51 percent year over year but still fell far short of the consensus Wall Street estimate.

For the three months ended March 31, 2018, the company's revenues were up to $801,000, compared to $530,000 in Q1 2017. The analysts' average estimate was $2.8 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.